Literature DB >> 17558599

Ischemia-reperfusion and cardioprotection: a delicate balance between reactive oxygen species generation and redox homeostasis.

Shyamal K Goswami1, Nilanjana Maulik, Dipak K Das.   

Abstract

Ischemia-reperfusion injury of the myocardium has long been a subject of intense research. Cardiac preconditioning, an associated phenomenon, has also been critically investigated over the past two decades. Although the biochemistry of ischemia-reperfusion and its association with oxidative metabolism has long been established, recent studies have further revealed a more intricate role of a number of reactive oxygen-nitrogen species in those processes. Emerging evidence suggests that an elaborate network of enzymes (and other biomolecules) dedicated to the generation, utilization, and diminution of reactive oxygen-nitrogen species maintains the redox homeostasis in the myocardium, and any perturbation of its status has distinctive effects. It thus appears that while excessive generation of reactive species leads to cellular injury, their regulated generation may cause transient and reversible modifications of cellular proteins leading the transmission of intracellular signals with specific effects. Taken together, generation of reactive oxygen-nitrogen species in the myocardium plays a nodal role in mediating both ischemic injury and cardioprotection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558599     DOI: 10.1080/07853890701374677

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  13 in total

1.  Determination of Angiotensin-(1-7) with HPLC/Fluorescence-Detection.

Authors:  Miriam Russ; Susanne Hauser; Reinhold Wintersteiger; Joachim Greilberger; Michaela Andrä; Astrid Ortner
Journal:  J Fluoresc       Date:  2015-10-09       Impact factor: 2.217

2.  Pump to survive: novel cytoprotective strategies for cardiac progenitor cells.

Authors:  Otmar Pfister; Ronglih Liao
Journal:  Circ Res       Date:  2008-05-09       Impact factor: 17.367

3.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

4.  Endoplasmic Reticulum Chaperone GRP78 Protects Heart From Ischemia/Reperfusion Injury Through Akt Activation.

Authors:  Xukun Bi; Guangyu Zhang; Xiaoding Wang; Chau Nguyen; Herman I May; Xiaoting Li; Ali A Al-Hashimi; Richard C Austin; Thomas G Gillette; Guosheng Fu; Zhao V Wang; Joseph A Hill
Journal:  Circ Res       Date:  2018-04-18       Impact factor: 17.367

Review 5.  Lipid raft redox signaling: molecular mechanisms in health and disease.

Authors:  Si Jin; Fan Zhou; Foad Katirai; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

6.  Targeted detoxification of selected reactive oxygen species in the vascular endothelium.

Authors:  Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Faiz Bhora; Karine Laude; Hua Cai; Sergei Dikalov; Evguenia Arguiri; Charalambos C Solomides; Steven M Albelda; David G Harrison; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2009-08-19       Impact factor: 4.030

Review 7.  Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.

Authors:  Ralph V Shohet; Joseph A Garcia
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

Review 8.  Cross talk between ceramide and redox signaling: implications for endothelial dysfunction and renal disease.

Authors:  Pin-Lan Li; Yang Zhang
Journal:  Handb Exp Pharmacol       Date:  2013

9.  Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide.

Authors:  Lafayete William F Ramos; Neif Murad; Eduardo Goto; Edinei L Antônio; José A Silva; Paulo F Tucci; Antônio C Carvalho
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037

Review 10.  NOX enzymes as novel targets for drug development.

Authors:  J David Lambeth; Karl-Heinz Krause; Robert A Clark
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.